David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
PUT
Lincoln National
LNC
$8.29B
| $3.74M | ﹤0.01% |
60,000
-68,200
| -53% | -$3.77M |
|
1952
Hackett Group
HCKT
$273M
| $3.73M | ﹤0.01% |
227,795
+2,787
| +1% | +$43.1K |
|
1953
Caesarstone
CSTE
$113M
| $3.73M | ﹤0.01% |
271,501
+53,738
| +25% | +$711K |
|
1954
Marriott Vacations Worldwide
VAC
$3.95B
| $3.73M | ﹤0.01% |
21,391
+9,099
| +74% | +$1.42M |
|
1955
Bio-Techne
TECH
$11.4B
| $3.71M | ﹤0.01% |
38,908
-4,576
| -11% | -$417K |
|
1956
Xos
XOS
$51.2M
| $3.71M | ﹤0.01% |
+12,482
| New | +$4.05M |
|
1957
CALL
Nutrien
NTR
$35.1B
| $3.71M | ﹤0.01% |
68,900
| – | – |
|
1958
PUT
BioMarin Pharmaceuticals
BMRN
$12.7B
| $3.7M | ﹤0.01% |
49,000
+9,000
| +23% | +$735K |
|
1959
Replimune Group
REPL
$1.5B
| $3.7M | ﹤0.01% |
121,257
+14,098
| +13% | +$528K |
|
|
DISCK
1960
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $3.69M | ﹤0.01% |
+100,000
| New | +$4.24M |
|
1961
PUT
Vodafone
VOD
$36.8B
| $3.69M | ﹤0.01% |
200,000
| – | – |
|
1962
CALL
Rio Tinto
RIO
$170B
| $3.68M | ﹤0.01% |
47,400
-72,600
| -61% | -$5.95M |
|
1963
CALL
Lemonade
LMND
$4.15B
| $3.68M | ﹤0.01% |
+39,500
| New | +$5.1M |
|
1964
HealthStream
HSTM
$841M
| $3.68M | ﹤0.01% |
164,570
-46,583
| -22% | -$1.11M |
|
|
HAYN
1965
DELISTED
Haynes International, Inc.
HAYN
| $3.68M | ﹤0.01% |
123,902
-24,143
| -16% | -$651K |
|
1966
Lamar Advertising Co
LAMR
$15.4B
| $3.67M | ﹤0.01% |
39,075
-122,218
| -76% | -$10.8M |
|
|
SCHW
1967
CALL
Charles Schwab
SCHW
$189B
| $3.67M | ﹤0.01% |
56,300
-43,700
| -44% | -$2.65M |
|
1968
Deluxe
DLX
$1.08B
| $3.66M | ﹤0.01% |
87,283
-114,710
| -57% | -$4.32M |
|
1969
Constellium
CSTM
$3.68B
| $3.66M | ﹤0.01% |
248,935
+53,672
| +27% | +$771K |
|
1970
Safety Insurance
SAFT
$1.52B
| $3.66M | ﹤0.01% |
43,409
+14,841
| +52% | +$1.19M |
|
1971
SLR Investment Corp
SLRC
$682M
| $3.65M | ﹤0.01% |
205,394
+105,129
| +105% | +$1.93M |
|
1972
SPX Corp
SPXC
$10.3B
| $3.64M | ﹤0.01% |
62,465
+6,024
| +11% | +$343K |
|
|
SUNL
1973
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $3.63M | ﹤0.01% |
+17,335
| New | +$4.06M |
|
1974
NNN REIT
NNN
$8.76B
| $3.61M | ﹤0.01% |
81,989
-84,816
| -51% | -$3.55M |
|
1975
CALL
Realty Income
O
$58.9B
| $3.59M | ﹤0.01% |
58,411
-55,315
| -49% | -$3.28M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.